Efficacy and safety of COVID‐19 vaccines

Cochrane Emergency and Critical Care … - Cochrane Database …, 1996 - cochranelibrary.com
Background Different forms of vaccines have been developed to prevent the SARS‐CoV‐2
virus and subsequent COVID‐19 disease. Several are in widespread use globally …

Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis

X Wu, K Xu, P Zhan, H Liu, F Zhang, Y Song… - BMC infectious diseases, 2024 - Springer
Background Over a dozen vaccines are in or have completed phase III trials at an
unprecedented speed since the World Health Organization (WHO) declared COVID-19 a …

Ongoing efforts to improve antimicrobial utilization in hospitals among African countries and implications for the future

Z Saleem, B Godman, A Cook, MA Khan, SM Campbell… - Antibiotics, 2022 - mdpi.com
There are serious concerns with rising antimicrobial resistance (AMR) across countries
increasing morbidity, mortality and costs. These concerns have resulted in a plethora of …

[HTML][HTML] Coronavirus disease 2019 (COVID-19) pandemic across Africa: current status of vaccinations and implications for the future

OO Ogunleye, B Godman, JO Fadare, S Mudenda… - Vaccines, 2022 - mdpi.com
The introduction of effective vaccines in December 2020 marked a significant step forward in
the global response to COVID-19. Given concerns with access, acceptability, and hesitancy …

Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA …

ME Toledo-Romaní, M García-Carmenate… - The Lancet Regional …, 2023 - thelancet.com
Background SOBERANA-02 is a COVID-19 conjugate vaccine (recombinant RBD
conjugated to tetanus toxoid). Phases 1/2 clinical trials demonstrated high immunogenicity …

Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies

JPA Ioannidis - BMJ Evidence-Based Medicine, 2022 - ebm.bmj.com
Non-randomised studies assessing COVID-19 vaccine effectiveness need to consider
multiple factors that may generate spurious estimates due to bias or genuinely modify …

[HTML][HTML] Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc?

A Baronti, F Gentile, AC Manetti, A Scatena… - Viruses, 2022 - mdpi.com
Vaccination against coronavirus disease 2019 (COVID-19) is the safest and most effective
strategy for controlling the pandemic. However, some cases of acute cardiac events …

Efficacy and safety of COVID‐19 vaccines: A network meta‐analysis

AA Toubasi, TN Al‐Sayegh, YY Obaid… - Journal of Evidence …, 2022 - Wiley Online Library
Objective Several vaccines showed a good safety profile and significant efficacy against
COVID‐19. Moreover, in the absence of direct head to head comparison between COVID …

Safety and effectiveness of COVID-19 vaccines during pregnancy: a living systematic review and meta-analysis

A Ciapponi, M Berrueta, FJ Argento, J Ballivian… - Drug safety, 2024 - Springer
Background Pregnant persons are susceptible to significant complications following COVID-
19, even death. However, worldwide COVID-19 vaccination coverage during pregnancy …